Omri Gottesman is the founder of Empirico. Empirico has raised $75M in total funding. Latest round: Series B. Based in San Diego, United States.
Omri Gottesman is the CEO and founder of Empirico, a biotechnology company focused on discovering and developing novel medicines. He has led the company through multiple funding rounds and strategic partnerships, including collaborations with Ionis Pharmaceuticals and GSK.
Full founder directory · Investor directory · Company funding database · Fundraising library